FindTrial
Sign In

Deep Sequencing of Plasma Cell-Free DNA for Detecting ALK or ROS1 Rearrangement in Patients with Advanced Non-Small Lung Cancer

Deep Sequencing of Plasma Cell-Free DNA for Detecting ALK or ROS1 Rearrangement in Patients with Advanced Non-Small Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15007185
Enrollment
Unknown
Registered
2015-10-10
Start date
2015-10-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

Interventions

Gold Standard:
Index test:

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Advanced NSCLC patients with ALK or ROS1 rearrangement

Exclusion criteria

Exclusion criteria: Patients with hemolysis or hypertriglyceridemia

Design outcomes

Primary

MeasureTime frame
diagnostic accuracy;—

Countries

China

Contacts

Public ContactWeimin Li
weimi003@yahoo.com+86 18602861441

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026